• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WRIGHTS LANE SYNTHES USA PRODUCTS LLC 5.0MM TI LOCKING SCR SLF-TPNG W/T25 STARDRIVE 40MM-STERILE; APPLIANCE, FIXATION, NAIL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WRIGHTS LANE SYNTHES USA PRODUCTS LLC 5.0MM TI LOCKING SCR SLF-TPNG W/T25 STARDRIVE 40MM-STERILE; APPLIANCE, FIXATION, NAIL Back to Search Results
Model Number 412.214S
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Bone Fracture(s) (1870); Impaired Healing (2378); No Code Available (3191)
Date of Event 06/01/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Date of event is an unknown date in (b)(6) 2019.Complainant part is not expected to be returned for manufacturer review/investigation.The investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.(b)(4).Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
It was reported that on (b)(6) 2019, the patient underwent revision surgery due to a subtrochanteric fracture subsequent to their initial fracture.The patient¿s original injury had not healed, and a second fracture occurred in the femur, just distal to the side plate.The surgeon removed all implants; femoral neck system plate, antirotation screw, femoral neck bolt, 40mm titanium locking screw and 30mm titanium locking screw.Patient was revised with a non-synthes gamma nail.Originally, the patient was treated for a femoral neck fracture on (b)(6) 2019.Procedure was successfully completed with no delay.Patient status is unknown.This report is for a 5.0mm titanium (ti) locking screw 40mm.This is report 4 of 5 for (b)(4).
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Part 412.214s, lot 2l56189: manufacturing site: mezzovico.Release to warehouse date: january 17, 2018.Expiry date: january 01, 2028.A manufacturing record evaluation was performed for the finished device lot number, and no non-conformances were identified.A product investigation was completed: the complaint device was not received for investigation.The investigation is based on the images/x-rays provided.The images were received showing no implant failure/defect.Per the images/x-rays, the reported adverse event of subtrochanteric fractures were identified (post-op).This complaint is confirmed; no device failure/defect was identified.During this investigation no product design or manufacturing issues were observed that may have contributed to the complaint condition.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post market safety surveillance activities.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
5.0MM TI LOCKING SCR SLF-TPNG W/T25 STARDRIVE 40MM-STERILE
Common Device Name
APPLIANCE, FIXATION, NAIL
Manufacturer (Section D)
WRIGHTS LANE SYNTHES USA PRODUCTS LLC
1302 wrights lane east
west chester PA 19380
MDR Report Key8823474
Report Number2939274-2019-59351
Device Sequence Number3206302
Product Code KTT
UDI-Device Identifier10886982275417
UDI-Public(01)10886982275417
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K000682
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number412.214S
Device Catalogue Number412.214S
Device Lot Number2L56189
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/27/2019
Supplement Date Received by Manufacturer08/01/2019
08/23/2019
Initial Report FDA Received Date07/24/2019
Supplement Report FDA Received Date08/22/2019
08/23/2019
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age71 YR
Patient Weight101
-
-